1-5 of 5
Jacopo Gervasoni
Close
Sort by
Journal Articles

Development of Mek inhibition (MEK-I)-Based Therapeutic Strategies in Acute Myeloid Leukemia (AML)

Michele Milella, MD, Maria Rosaria Ricciardi, Paola Bergamo, MS, Maria Cristina Scerpa, PhD, Jacopo Gervasoni, MS, Maria Teresa Petrucci, MD, Sabina Chiaretti, MD, Simona Tavolaro, MS, Ludovica Ciuffreda, PhD, Samantha Decandia, Francesco Libotte, Stephen Lee Abrams, Linda S Steelman, BS., MS, Marina Konopleva, MD, PhD, Francesco Cognetti, MD, Robert Foa, Michael Andreeff, MD, PhD, James McCubrey, PhD, Agostino Tafuri
Journal: Blood
Blood (2008) 112 (11): 860.
https://doi.org/10.1182/blood.V112.11.860.860
Published: 2008
Journal Articles

The Methylation Status of p21 Is Not Relevant in Adult Acute Lymphoblastic Leukemia Patients.

Chiara Gregorj, PhD, Fabiana De Cave, PhD, Maria R. Ricciardi, PhD, Maria C. Scerpa, PhD, Cristina M. Precupanu, MD, Jacopo Gervasoni, Maria L. Iannitto, Paola Fazi, MD, Stefania Gubbiotti, MSC, Giorgina Specchia, MD, Alessandra Cupri, MD, Felicetto Ferrara, MD, Francesca Mondello, MD, Ciro Rinaldi, MD, Giuseppe Fioritoni, MD, Nicola Cascavilla, MD, Eustachio Miraglia, MD, Luciana Annino, MD, Ernesta Audisio, MD, Patrizio Mazza, MD, Antonio Peta, MD, Alfonso M. D’Arco, MD, Catia Bigatti, MD, Alessandra Tedeschi, MD, Robin Foà, MD, Agostino Tafuri, MD, Maria Teresa Petrucci, MD
Journal: Blood
Blood (2005) 106 (11): 4552.
https://doi.org/10.1182/blood.V106.11.4552.4552
Published: 2005
Journal Articles

Effective Targeting of MEK/ERK Signalling at Nanomolar Concentrations by the Novel Small Molecule Inhibitor PD0325901 in Hematopoietic and Solid Tumors.

Maria R. Ricciardi, PhD, Maria C. Scerpa, PhD, Ludovica Ciuffreda, PhD, Sabina Chiaretti, MD, PhD, Simona Tavolaro, PhD, Jacopo Gervasoni, Fabiana De Cave, PhD, Chiara Gregorj, PhD, Maria T. Petrucci, MD, Francesco Cognetti, MD, Michael Andreeff, MD, PhD, Gabriella Zupi, MD, Robin Foà, MD, Agostino Tafuri, MD, Michele Milella, MD
Journal: Blood
Blood (2005) 106 (11): 3370.
https://doi.org/10.1182/blood.V106.11.3370.3370
Published: 2005
Journal Articles

Role of Extracellular Signal-Regulated Kinase-1/2 (ERK) on Complete Remission Achievement of Primary Adult Acute Lymphoblastic Leukemia Patients Enrolled in the GIMEMA Protocol LAL 2000: In Vitro Activity of the MEK Inhibithor PD98059.

Chiara Gregorj, PhD, Maria T. Petrucci, MD, Maria C. Scerpa, PhD, Maria R. Ricciardi, PhD, Fabiana De Cave, PhD, Jacopo Gervasoni, Marco Vignetti, MD, Stefania Gubbiotti, MSC, Cristina Ariola, Giorgina Specchia, MD, Annalisa Chiarenza, MD, Felicetto Ferrara, MD, Francesco Fabbiano, MD, Andrea Camera, MD, Giuseppe Fioritoni, MD, Eustachio Miraglia, MD, Luciana Annino, MD, Federico Mosna, MD, Nicola Cantore, MD, Mario Luppi, MD, Francesco Nobile, MD, Giuseppe Leone, MD, Lorella Depaoli, MD, Antonio Peta, MD, Massimo A. Martelli, MD, Ignazio Majolino, MD, Marco Montanaro, MD, Michele Milella, MD, Giovanna Meloni, MD, Robert Foà, MD, Agostino Tafuri, MD
Journal: Blood
Blood (2005) 106 (11): 853.
https://doi.org/10.1182/blood.V106.11.853.853
Published: 2005
Journal Articles

Breast Cancer Resistance Protein (BCRP) Expression Affects Event-Free Survival in Adult Acute Lymphoblastic Leukemia Patients Uniformly Treated According to the GIMEMA LAL 2000 Protocol.

Chiara Gregorj, PhD, Maria T. Petrucci, MD, Fabiana De Cave, PhD, Maria C. Scerpa, PhD, Maria R. Ricciardi, PhD, Jacopo Gervasoni, Maria L. Iannitto, Marco Vignetti, MD, Paola Fazi, MD, Antonella Vitale, MD, Giovanna Meloni, MD, Vincenzo Liso, MD, Francesco Di Raimondo, MD, Felicetto Ferrara, MD, Francesco Fabbiano, MD, Andrea Camera, MD, Giuseppe Fioritoni, MD, Eustachio Miraglia, MD, Luciana Annino, MD, Nicola Cascavilla, MD, Filippo Marmont, MD, Patrizio Mazza, MD, Omar Perbellini, MD, Nicola Cantone, MD, Mario Luppi, MD, Francesco Nobile, MD, Simona Sica, MD, Flavia Salvi, MD, Robin Foa’, MD, Agostino Tafuri, MD
Journal: Blood
Blood (2005) 106 (11): 854.
https://doi.org/10.1182/blood.V106.11.854.854
Published: 2005